Advertisement
Advertisement
Investor Relations /

IPO Quote Profile

Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

videocam
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

videocam
Banking & finance

Hong Kong attracts wave of biotech IPO filings amid AI drug research boom

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.

The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
The latest applications come as healthcare and biotechnology equity capital market activity in Hong Kong reached US$15.6 billion last year. Illustration: Shutterstock
Banking & finance

China investors energise Hong Kong biotech stocks. Is foreign money missing out?

Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.

IPO

Hong Kong’s IPO pace picks up as 2 mainland Chinese firms get listing approval

Everdisplay Optronics and Galaxis Technology publish post-hearing information packs on the Hong Kong stock exchange.

Advertisement
Advertisement
Advertisement
IPO

HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings

Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.

Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
Bull statues are seen in front of the Shenzhen Stock Exchange on November 17, 2024. Photo: Getty Images
IPO

Shenzhen-listed Unisplendour abandons plan to raise funds in Hong Kong

The Tsinghua Holdings arm, however, will raise US$800 million via a private share placement on Shenzhen exchange.

Made in China 2025

Chinese healthcare firms expand overseas to support growing expat community

Privately owned Distinct Healthcare plans to open a clinic in Dubai, while TCM group Gushengtang eyes 50 centres in Southeast Asia.

Hong Kong

AI chip supplier Axera trades flat in Hong Kong debut as investor frenzy cools

Axera attracted HK$22.34 billion from retail investors during the bookbuilding period, marking an oversubscription of 74.4 times.

Axera specialises in designing AI perception and edge computing chips for applications such as smart vehicles. Photo: Handout
IPO

China’s biggest pork producer Muyuan flat in Hong Kong share debut

Firm’s US$1.4 billion IPO records lower oversubscription rate than other recent listings, reflecting a cooling of the red-hot market.

Muyuan Foods chairman Qin Yinglin (left) takes part in the company’s listing ceremony at Hong Kong Exchanges and Clearing on February 6, 2026. Photo: Jonathan Wong
Muyuan Foods chairman Qin Yinglin (left) takes part in the company’s listing ceremony at Hong Kong Exchanges and Clearing on February 6, 2026. Photo: Jonathan Wong
IPO

3 Chinese firms add to Hong Kong’s IPO boom with US$2 billion in fundraising

Muyuan Foods, Shenzhen Han’s and Distinct Healthcare started taking orders for their Hong Kong listings on Thursday.

IPO

Chinese drinks maker Eastroc’s US$1.3 billion Hong Kong IPO gives it wings

Shanghai-listed firm is selling 40.9 million shares for HK$248 each, which would give it a market cap of about US$21 billion.

Mainland China

China’s rocket start-ups push the envelope as IPOs gather pace

A policy-backed push to build commercial space champions is reshaping China’s IPO pipeline, with regulators signalling faster pathways.

A Zhuque-3 rocket by China’s private rocket firm LandSpace takes off from the Jiuquan Satellite Launch Centre. Photo: Handout
IPO

China’s Busy Ming to test investor appetite with Hong Kong IPO

Snack and drink retailer aims to raise up to US$428 million, but listing plan comes amid weak mainland domestic demand.

Hong Kong’s IPO market has had a record January with 11 new listings raising more than US$4.3 billion. Photo: Nora Tam
Hong Kong’s IPO market has had a record January with 11 new listings raising more than US$4.3 billion. Photo: Nora Tam
IPO

Chinese AI start-up MiniMax shines on Hong Kong IPO debut

The shares jump as much as 113.2 per cent to HK$351.80 before ending the day 109.1 per cent higher at HK$345.

Banking & finance

TCM firms eye Hong Kong IPOs to fuel global expansion

Over the past year, 34 innovation and technology, life and health science companies set up or expanded their operations in Hong Kong.

Advertisement
Advertisement
Advertisement
IPO

3 Chinese AI, robotics stocks gain in Hong Kong debuts

Zhipu AI, Iluvatar CoreX and Edge Medical raised US$1.2 billion in their share offerings.

Zhipu AI is the first pure-play Chinese AI large language model developer traded on the Hong Kong stock exchange. Photo: Shutterstock
Zhipu AI is the first pure-play Chinese AI large language model developer traded on the Hong Kong stock exchange. Photo: Shutterstock
IPO

MiniMax’s Hong Kong IPO set to hit US$538 million amid Chinese AI sector frenzy

The Alibaba-backed firm is set to price its 25.4 million shares at HK$165 each, the top end of its marketed range, sources say.

Banking & finance

The ‘biology winter’ thaws: why investors are buying Hong Kong’s biotech IPOs

A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging.

Hong Kong

Baidu spin-off Kunlunxin joins wave of Chinese semiconductor IPOs in Hong Kong

Last year, 20 Chinese semiconductor IPOs raised over 45 billion yuan (US$6.4 billion), with six of them listing in December.

The Baidu logo is pictured at the company’s headquarters in Beijing, March 16, 2023. Photo: Reuters
IPO

Shares in Chinese GPU start-up Biren soar in Hong Kong listing

Shares leap 82 per cent in debut after retail investors’ demand exceeds supply by 2,347 times.

Zhang Wen, chairman and CEO of Biren, bangs the gong at the company’s listing ceremony in Hong Kong on January 2, 2026, as HKEX CEO Bonnie Chan (left) and Financial Secretary Paul Chan (second from right) look on. Photo: Jonathan Wong
Zhang Wen, chairman and CEO of Biren, bangs the gong at the company’s listing ceremony in Hong Kong on January 2, 2026, as HKEX CEO Bonnie Chan (left) and Financial Secretary Paul Chan (second from right) look on. Photo: Jonathan Wong
IPO

China’s DRAM giant CXMT plans US$4.2 billion IPO on Shanghai’s Star Market

Listing aims to fund wafer expansion and DRAM upgrades as Beijing drives tech self-reliance.

IPO

China AI start-up MiniMax kicks off US$538 million Hong Kong IPO

Start of Shanghai-based company’s share sale follows launch of rival Zhipu’s US$560 million IPO a day earlier.

IPO

China’s Zhipu AI launches US$560 million share sale amid heated IPO tech race

The company, marketed overseas as Z.ai, eyes US$6.6 billion valuation with Hong Kong’s first large language model listing.

Zhipu AI is moving closer to becoming the first large language model developer listed in Hong Kong. Photo: Shutterstock
Help preserve 120 years of quality journalism.
SUPPORT NOW